| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773785A2 Treatment of cancer using hsv mutant |
| 05/21/1997 | EP0679187B1 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 05/21/1997 | EP0660844A4 Isolated nucleotide sequences for identifying neisseria gonorrhoeae. |
| 05/21/1997 | EP0632836B1 Process for producing 17alpha-hydroxy-3-methoxy-8,14-seco-1,3,5(10),9(11) estratetraene-14-one |
| 05/21/1997 | EP0567644B1 Process for producing l-alanine by fermentation |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | EP0409928B1 Expression of proteinaceous sweeteners in yeast |
| 05/21/1997 | CN1150459A L-ascorbic acid production in microorganisms |
| 05/21/1997 | CN1150457A Gene imparting flocculability to yeast and gene product |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631238 Anticarcinogenic agents |
| 05/20/1997 | US5631223 Cyclic oligopeptides |
| 05/20/1997 | US5631157 Having a genetically engineered plasmid to impart stability during fermentation |
| 05/20/1997 | US5631149 Variant-type carbohydrate hydrolase, variant gene of the enzyme and method for producing oligosaccharide using the enzyme |
| 05/20/1997 | US5631144 Application of novel DNA fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeast and corresponding process for the preparation of proteins |
| 05/20/1997 | US5631143 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 05/20/1997 | US5631010 Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1 |
| 05/20/1997 | CA2053736C Process for producing antibiotics |
| 05/15/1997 | WO1997017451A2 Production of gad65 in methylotrophic yeast |
| 05/15/1997 | WO1997017450A2 Compositions and methods for producing heterologous polypeptides in pichia methanolica |
| 05/15/1997 | WO1997017449A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017440A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | WO1997017427A1 Novel process for the propagation of b. pertussis |
| 05/15/1997 | WO1997017373A1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 05/15/1997 | WO1997003635A3 P16 expression constructs and their application in cancer therapy |
| 05/15/1997 | WO1997001640A3 Vaccines against hepatitis c |
| 05/15/1997 | DE19534763C1 FMR1-verwandtes Protein FMR1-related protein |
| 05/15/1997 | CA2237039A1 Production of gad65 in methylotrophic yeast |
| 05/15/1997 | CA2235631A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | CA2234683A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | CA2229444A1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 05/14/1997 | EP0773295A2 DNA-based vaccination of fish by immersion |
| 05/14/1997 | EP0773294A2 Efficient directional genetic cloning system |
| 05/14/1997 | EP0773293A2 Genetically engineered tumour cell lines and their use in the screening of antitumour-compositions |
| 05/14/1997 | EP0773291A2 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 05/14/1997 | EP0773290A2 Novel LDL receptor analog protein and the gene coding therefor |
| 05/14/1997 | EP0773289A2 Asialoglycoprotein receptor derivatives and their use |
| 05/14/1997 | EP0773287A1 Immortalised embryonic hyppocampal cells and their use |
| 05/14/1997 | EP0773192A1 Selenium containing sewage treatment process and apparatus |
| 05/14/1997 | EP0772691A1 Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |
| 05/14/1997 | EP0772686A1 Novel topoisomerase iv, corresponding nucleotide sequences and uses thereof |
| 05/14/1997 | EP0772685A1 Heat-stable prolylendopeptidase |
| 05/14/1997 | EP0772683A1 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 05/14/1997 | EP0772680A1 A polynucleotide herpes virus vaccine |
| 05/14/1997 | EP0772676A1 Method of control of microorganism growth process |
| 05/14/1997 | EP0772632A2 T cell stimulating protein of pestivirus |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0772399A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | EP0621897B1 Process for preparing lignolytic enzymes by means of white rot fungi |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149888A 流感疫苗 Influenza vaccination |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/13/1997 | US5629469 Peptide virgiferin and variations; recombinant dna molecule with nucleic acid sequence encoding peptide; transgenic plant with foreign gene encoding peptide; combatting insects with peptide; host cell transformed with vector as described |
| 05/13/1997 | US5629414 Dna molecule coding for surface antigen of toxoplama gondii, vaccines |
| 05/13/1997 | US5629205 Promoters for gene expression |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629181 Synthesis of catechol from biomass-derived carbon sources |
| 05/13/1997 | US5629180 Process for producing L-amino acid |
| 05/13/1997 | US5629176 Dna construct comprising dna sequence encoding the variant; recombinant expression vector comprising the construct; host cell containing the construct or vector; culture process for making the variant; pharmaceutical comprising the variant |
| 05/13/1997 | US5629175 Molecular farming |
| 05/13/1997 | US5629174 Dna, rna |
| 05/13/1997 | US5629172 Ubiquitin molecule is cleavage site |
| 05/13/1997 | US5629171 Recombinant bioprocess for the preparation of 7-amino cephalosporanic acid (7-ACA) |
| 05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| 05/13/1997 | US5629159 Immortalization and disimmortalization of cells |
| 05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
| 05/09/1997 | WO1997016564A1 Improved is6110 based molecular detection of mycobacterium tuberculosis |
| 05/09/1997 | WO1997016558A1 Positive selection vector for bacillus sp. |
| 05/09/1997 | WO1997016552A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | WO1997016551A1 Human hepatitis b virus dna |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016546A1 Molecular cloning by multimerization of plasmids |
| 05/09/1997 | WO1997016541A1 Alkaline protease, process for the production thereof, use thereof, and microorganism producing the same |
| 05/09/1997 | WO1997016540A1 Chitin synthase 1 |
| 05/09/1997 | WO1997016530A1 New e.coli mutant with suppressed organic acid production |
| 05/09/1997 | WO1997016528A1 A mutant e. coli strain with increased succinic acid production |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016458A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016175A1 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 05/09/1997 | WO1997004089A3 Porphyrin-accumulating type herbicide resistance gene |
| 05/09/1997 | CA2236448A1 Molecular cloning by multimerization of plasmids |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2236274A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | CA2235623A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | CA2234667A1 Human hepatitis b virus dna |
| 05/09/1997 | CA2233881A1 Chitin synthase 1 |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/09/1997 | CA2208871A1 New e.coli mutant with suppressed organic acid production |
| 05/08/1997 | CA2189499A1 Immortalised embryonic hippocampal cells and their use |